Insulet Corp. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Insulet Corp. (PODD) shares fell 2.02% to $131.96 on Friday, underperforming the broader market as the S&P 500 and Dow Jones rose. This marks the stock's fifth consecutive day of losses, with the price now 62.82% below its 52-week high of $354.88. Trading volume reached 1.7 million, exceeding the 50-day average. Compared to competitors like Eli Lilly, DexCom, and Johnson & Johnson, Insulet also lagged in performance.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) slid 2.02% to $131.96 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.86% to 7,656.98 and the Dow Jones Industrial Average rising 0.98% to 52,573.29.
This was the stock's fifth consecutive day of losses.
Insulet Corp. closed 62.82% short of its 52-week high of $354.88, which the company achieved on November 20th.
The stock underperformed when compared to some of its competitors Friday, as Eli Lilly & Co. (LLY) fell 0.65% to $1,115.70, DexCom Inc. (DXCM) fell 1.75% to $83.03, and Johnson & Johnson (JNJ) fell 0.29% to $265.58.
Trading volume (1.7 M) eclipsed its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-11-26 1717ET